148 related articles for article (PubMed ID: 2948444)
1. In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin.
Debbia E; Varaldo PE; Schito GC
Antimicrob Agents Chemother; 1986 Nov; 30(5):813-5. PubMed ID: 2948444
[TBL] [Abstract][Full Text] [Related]
2. In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci.
Debbia E; Pesce A; Schito GC
J Hosp Infect; 1986 Mar; 7 Suppl A():73-7. PubMed ID: 2871100
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
[TBL] [Abstract][Full Text] [Related]
4. [In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
Quentin C; Noury P; Laurent C; Saivin S; Bebear C
Pathol Biol (Paris); 1987 Feb; 35(2):153-7. PubMed ID: 3550623
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.
Tuazon CU; Miller H
Antimicrob Agents Chemother; 1984 Apr; 25(4):411-2. PubMed ID: 6233934
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activity of teicoplanin alone and in combination with rifampicin, gentamicin or tobramycin against coagulase-negative staphylococci.
Watanakunakorn C
J Antimicrob Chemother; 1987 Apr; 19(4):439-43. PubMed ID: 2953706
[TBL] [Abstract][Full Text] [Related]
7. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.
Barr JG; Smyth ET; Hogg GM
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):804-9. PubMed ID: 2150814
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
Simon VC; Simon M
Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
Tessier F; Quentin C
Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
[TBL] [Abstract][Full Text] [Related]
10. [In vitro study of the effects of an imipenem-fosfomycin combination against clinical strains of Staphylococcus].
Fosse T; David MF; Duluc F
Pathol Biol (Paris); 1986 Dec; 34(10):1055-9. PubMed ID: 3547260
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.
Dixson S; Brumfitt W; Hamilton-Miller JM
Eur J Clin Microbiol; 1985 Feb; 4(1):19-23. PubMed ID: 3157567
[TBL] [Abstract][Full Text] [Related]
12. In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.
Yoon J; Urban C; Terzian C; Mariano N; Rahal JJ
Antimicrob Agents Chemother; 2004 Mar; 48(3):753-7. PubMed ID: 14982760
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of fosfomycin against 'problem' gram-positive cocci.
Hamilton-Miller JM
Microbios; 1992; 71(287):95-103. PubMed ID: 1453987
[TBL] [Abstract][Full Text] [Related]
15. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
[TBL] [Abstract][Full Text] [Related]
16. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
Thamlikitkul V
J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
[TBL] [Abstract][Full Text] [Related]
18. In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.
Chandrasekar PH; Price S; Levine DP
J Antimicrob Chemother; 1985 Aug; 16(2):179-82. PubMed ID: 2933380
[TBL] [Abstract][Full Text] [Related]
19. [Combination between fosfomycin and oxacillin or cefotaxime against methicillin-resistant Staphylococci and Enterococci].
Duez JM; Kohli E; Pechinot A; Tremeaux JC; Kazmierczak A
Pathol Biol (Paris); 1983 Jun; 31(6):515-8. PubMed ID: 6308543
[TBL] [Abstract][Full Text] [Related]
20. In vitro additive effect of imipenem combined with vancomycin against multiple-drug resistant, coagulase-negative Staphylococci.
Traub WH; Spohr M; Bauer D
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Sep; 262(3):361-9. PubMed ID: 3466493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
